Cargando…
Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features
SUMMARY: Middle ear adenomas with neuroendocrine features (ANEF) are rare, with an estimated 150 reported cases. They usually pursue an indolent clinical course. Four reported cases of middle ear ANEF with distant metastases were treated with surgery, external beam radiation therapy (EBRT) and chemo...
Autores principales: | Lima Ferreira, Joana, Marques, Bernardo, Menke-van der Houven van Oordt, C Willemien, de Herder, Wouter W, Brabander, Tessa, Hofland, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185540/ https://www.ncbi.nlm.nih.gov/pubmed/33982661 http://dx.doi.org/10.1530/EDM-20-0172 |
Ejemplares similares
-
Somatostatin analog challenge test in the pre-surgical management of ACTH-secreting pheochromocytoma
por: Rossini, Alessandro, et al.
Publicado: (2019) -
TSH-secreting pituitary adenoma: benefits of pre-operative octreotide
por: Wallace, I R, et al.
Publicado: (2015) -
Severe Cushing’s syndrome from an ectopic adrenocorticotropic hormone-secreting neuroendocrine tumour treated by osilodrostat
por: Hána, Václav, et al.
Publicado: (2023) -
Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
por: da Silva, Tiago Nunes, et al.
Publicado: (2018) -
New Methods for Direct Delivery of Chemotherapy for Treating Brain Tumors
por: Sawyer, Andrew J., et al.
Publicado: (2007)